Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Empirican Group
Salt Lake City, Utah, United Statesempirican.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Empirican Group is a clinical research site management organization (SMO) that specializes in optimizing the clinical trial process through a network of high-performing investigative sites. The company provides comprehensive support for Phase I-IV clinical trials, focusing on patient recruitment, site operations, and data quality. By integrating technology and standardized processes across its network, Empirican aims to accelerate drug development timelines for pharmaceutical and biotechnology sponsors. In 2020, the company was acquired by CenExel Clinical Research, expanding CenExel's footprint in the clinical trial site industry.
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on Empirican Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Empirican Group.